THE ROLE OF INFLAMMATION IN KERATOCONUS: AN UPDATED REVIEW OF CURRENT EVIDENCE
DOI:
https://doi.org/10.71000/kdpnzg75Keywords:
Keratoconus; inflammation; tear-film biomarkers; cytokines; matrix metalloproteinases; oxidative stress; eye rubbing; corneal collagen cross-linkingAbstract
Background: Keratoconus is a progressive corneal ectatic disorder characterized by stromal thinning, anterior corneal protrusion, irregular astigmatism, and gradual visual deterioration. Although it has traditionally been considered a non-inflammatory disease, increasing molecular, genetic, and clinical evidence suggests that chronic low-grade inflammation may contribute to its development and progression.
Objective: This narrative review aims to summarize current evidence on the role of inflammation in keratoconus, with emphasis on tear-film cytokines, matrix metalloproteinases, oxidative stress, genetic susceptibility, environmental triggers, inflammatory biomarkers, and emerging therapeutic implications.
Methods: A narrative literature review was conducted using relevant peer-reviewed articles from major scientific databases. Evidence was synthesized thematically to discuss inflammatory mechanisms, molecular pathways, ocular surface factors, clinical implications, and future directions in keratoconus research and management.
Main Findings: Current evidence indicates that patients with keratoconus may show increased levels of inflammatory mediators, including interleukin-1β, interleukin-6, tumor necrosis factor-alpha, high-mobility group box 1, and matrix metalloproteinases. These mediators may contribute to extracellular matrix degradation, keratocyte dysfunction, stromal thinning, and progressive corneal weakening. Oxidative stress, cellular senescence, allergy, atopy, dry eye disease, and habitual eye rubbing may further amplify inflammatory activity at the ocular surface. Recent genetic and molecular studies also suggest that keratoconus susceptibility may involve both biomechanical and atopy–inflammatory pathways. Corneal collagen cross-linking remains the established treatment for progressive disease, while anti-inflammatory, exosome-based, intense pulsed light, and nutritional approaches remain supportive or investigational.
Conclusion: Keratoconus should not be viewed as a purely biomechanical disorder. Current evidence supports a broader inflammatory-degenerative model in which inflammation, oxidative stress, genetic susceptibility, ocular surface disease, and environmental factors interact to influence disease progression. Further longitudinal studies, standardized biomarker validation, and controlled clinical trials are needed before inflammatory markers or emerging therapies can be incorporated into routine keratoconus care.
Keywords: Keratoconus; inflammation; tear-film biomarkers; cytokines; matrix metalloproteinases; oxidative stress; eye rubbing; corneal collagen cross-linking
References
Claessens JL, Godefrooij DA, Vink G, Frank LE, Wisse RP. Nationwide epidemiological approach to identify associations between keratoconus and immune-mediated diseases. British Journal of Ophthalmology [Internet]. BMJ Publishing Group Ltd; 2022 [cited 2026 June 26];106(10):1350–4. Available from: https://bjo.bmj.com/content/106/10/1350.abstract
Hafezi F, Gomes JÁP, Hillen M, Ambrósio Jr R. The Global Consensus on Keratoconus 2: From Definitions to Decision Making. [Internet]. Vol. 45, Cornea LWW; 2026 [cited 2026 June 26]. p. 909–10.
Singh RB, Koh S, Sharma N, Woreta FA, Hafezi F, Dua HS, et al. Keratoconus. Nature Reviews Disease Primers [Internet]. Nature Publishing Group UK London; 2024 [cited 2026 June 26];10(1):81. Available from: https://www.nature.com/articles/s41572-024-00565-3
Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent SJ, Wolffsohn JS. Keratoconus: an updated review. Contact Lens and Anterior Eye [Internet]. Elsevier; 2022 [cited 2026 June 26];45(3):101559. Available from: https://www.sciencedirect.com/science/article/pii/S1367048421002058
Doroodgar F, Alizadeh F, Niazi S, Razavi SM, Jalilian N, Azarnezhad A, et al. Inflammatory and genomic interactions within keratoconus susceptible patients: a nationwide registered case–control study. Eye and Vis. 2024;11(1):40. DOI: 10.1186/s40662-024-00407-z
Singh RB, Parmar UPS, Jhanji V. Prevalence and economic burden of keratoconus in the United States. American journal of ophthalmology [Internet]. Elsevier; 2024 [cited 2026 June 26];259:71–8. Available from: https://www.sciencedirect.com/science/article/pii/S0002939423004646
Gatzioufas Z, d PANOS G, Hamada S. Keratoconus: is it a Non-inflammatory Disease? Medical Hypothesis, Discovery and Innovation in Ophthalmology [Internet]. 2017 [cited 2026 June 26];6(1):1. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5392225/
Murthy SI, Mishra DK, Rathi VM. Pathophysiology and Histopathology of Keratoconus. In: Das S, editor. Keratoconus. Singapore: Springer Nature Singapore; 2022. DOI: 10.1007/978-981-19-4262-4_4
Chen X, Liu C, Cui Z, Huang Y, Luo Q, Chen S, et al. Integrative transcriptomics analysis and experimental validation reveal immunomodulatory patterns in keratoconus. Experimental Eye Research [Internet]. Elsevier; 2023 [cited 2026 June 26];230:109460. Available from: https://www.sciencedirect.com/science/article/pii/S0014483523000817
Meng F, Ren S. Identification of hub genes and molecular pathways in keratoconus by integrating bioinformatics and literature mining at the RNA level. Int Ophthalmol. 2024;44(1):244. DOI: 10.1007/s10792-024-03071-3
Santos A, José Filho APM, Cenedeze MA, Hiyane MI, Amano MT, Cruz MC, et al. Increased inflammatory mediators in the ocular surface tissue in keratoconus. Molecular Vision [Internet]. 2024 [cited 2026 June 26];30:279. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11575844/
Zhang X, Cui F, Wang Q, Zhang C. Inflammation and keratoconus: A comprehensive bidirectional Mendelian randomization analysis. Medicine [Internet]. LWW; 2024 [cited 2026 June 26];103(30):e39067. Available from: https://journals.lww.com/md-journal/fulltext/2024/07260/inflammation_and_keratoconus__a_comprehensive.75.aspx?context=latestarticles
Nichani PAH, Solomon B, Trinh T, Mimouni M, Rootman D, Singal N, et al. Investigating the role of inflammation in keratoconus: A retrospective analysis of 551 eyes. European Journal of Ophthalmology. 2023;33(1):35–43. DOI: 10.1177/11206721221125013
Kempuraj D, Mohan RR. Autophagy in extracellular matrix and wound healing modulation in the cornea. Biomedicines [Internet]. MDPI; 2022 [cited 2026 June 26];10(2):339. Available from: https://www.mdpi.com/2227-9059/10/2/339
Pinheiro-Costa J, Lima Fontes M, Luís C, Martins S, Soares R, Madeira D, et al. Serum inflammatory biomarkers are associated with increased choroidal thickness in keratoconus. Scientific Reports [Internet]. Nature Publishing Group UK London; 2023 [cited 2026 June 26];13(1):10862. Available from: https://www.nature.com/articles/s41598-023-37472-8
Wisse RP, Kuiper JJ, Gans R, Imhof S, Radstake TR, Van der Lelij A. Cytokine expression in keratoconus and its corneal microenvironment: a systematic review. The ocular surface [Internet]. Elsevier; 2015 [cited 2026 Jan 14];13(4):272–83. Available from: https://www.sciencedirect.com/science/article/pii/S1542012415000531
Kaiserman I, Sella S. Chronic Ocular Inflammation and Keratoconus. In: Barbara A, editor. Controversies in the Management of Keratoconus. Cham: Springer International Publishing; 2019. DOI: 10.1007/978-3-319-98032-4_2
Gil P, Gil JQ, Cruz N, Costa C, Rodrigues-Santos P, Sousa LM, et al. Persistent Proinflammatory Cytokine Profile in the Tear Fluid of Stable Keratoconus: Rethinking Clinical Quiescence. Translational Vision Science & Technology [Internet]. The Association for Research in Vision and Ophthalmology; 2025 [cited 2026 June 26];14(9):31–31. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2810859
Elbeyli A, Kurtul BE. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus. Indian journal of ophthalmology [Internet]. Medknow; 2021 [cited 2026 June 26];69(7):1725–9. Available from: https://journals.lww.com/ijo/fulltext/2021/07000/systemic_immune_inflammation_index,.18.aspx
Chen J, Jia Y, Qi X. Mendelian randomization and genetic analyses reveal causal roles of immune cells and inflammatory proteins in keratoconus. Scientific Reports [Internet]. Nature Publishing Group UK London; 2025 [cited 2026 June 26];15(1):25846. Available from: https://www.nature.com/articles/s41598-025-10759-8
Prause O, Bozinovski S, Anderson GP, Linden A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax [Internet]. BMJ Publishing Group Ltd; 2004 [cited 2026 June 26];59(4):313–7. Available from: https://thorax.bmj.com/content/59/4/313.short
Nichani PAH, Solomon B, Trinh T, Mimouni M, Rootman D, Singal N, et al. Investigating the role of inflammation in keratoconus: A retrospective analysis of 551 eyes. European Journal of Ophthalmology. 2023;33(1):35–43. DOI: 10.1177/11206721221125013
Akoto T. Biomechanical and Genetic Factors Contributing to Keratoconus Pathogenesis [PhD Thesis internet]. Augusta University; 2023 [cited 2026 Jan 3]. Available from: https://search.proquest.com/openview/ab12bfb1fe4945ff8f54e372260f493d/1?pq-origsite=gscholar&cbl=18750&diss=y
Yu Y, Liu Q, Zhou C, Jiang J, Li Y. Genetic and immune landscape of keratoconus: insights from Mendelian randomization analysis. Mamm Genome. 2025;36(3):859–71. DOI: 10.1007/s00335-025-10135-x
Chiou GCY, Xuan B, Liu Q, Yamasaki T, Okawara T. Inhibition of Interleukin-1-Induced Uveitis and Corneal Fibroblast Proliferation by Interleukin-1 Blockers. Journal of Ocular Pharmacology and Therapeutics. 2000;16(5):407–18. DOI: 10.1089/jop.2000.16.407
Hao X-D, Chen P, Chen Z-L, Li S-X, Wang Y. Evaluating the Association between Keratoconus and Reported Genetic Loci in a Han Chinese Population. Ophthalmic Genetics. 2015;36(2):132–6. DOI: 10.3109/13816810.2015.1005317
Tur VM, MacGregor C, Jayaswal R, O’Brart D, Maycock N. A review of keratoconus: diagnosis, pathophysiology, and genetics. Survey of ophthalmology [Internet]. Elsevier; 2017 [cited 2025 Mar 25];62(6):770–83. Available from: https://www.sciencedirect.com/science/article/pii/S0039625717300462
Cejka C, Cejkova J. Oxidative Stress to the Cornea, Changes in Corneal Optical Properties, and Advances in Treatment of Corneal Oxidative Injuries. Oxidative Medicine and Cellular Longevity. Wiley; 2015;2015:1–10. DOI: 10.1155/2015/591530
Abdul‐Maksoud RS, Fouad RA, Elsayed TG, Ibrahem RA, Badawi AE. The impact of catalase and glutathione peroxidase‐1 genetic polymorphisms on their enzyme activities among Egyptian patients with keratoconus. The Journal of Gene Medicine. 2020;22(8):e3192. DOI: 10.1002/jgm.3192
Gu C, Wang L, Jiang Q, Gu Z, Li X, Yao Y, et al. Exploring the oxidative stress-related molecular clusters in the cornea of patients with keratoconus. Experimental Eye Research [Internet]. Elsevier; 2025 [cited 2026 June 26];110516. Available from: https://www.sciencedirect.com/science/article/pii/S0014483525002878
Huang RS, Mihalache A, Popovic MM, Chan CC. Evaluating Changes in Pro-and Anti-Inflammatory Mediators in Keratoconus Following Corneal Collagen Cross-linking: A Systematic Review: Pro-and Anti-Inflammatory Mediators Following Corneal CXL. AJO International [Internet]. Elsevier; 2025 [cited 2026 June 26];100185. Available from: https://www.sciencedirect.com/science/article/pii/S2950253525000899
Sahebjada S, Al-Mahrouqi HH, Moshegov S, Panchatcharam SM, Chan E, Daniell M, et al. Eye rubbing in the aetiology of keratoconus: a systematic review and meta-analysis. Graefe’s Archive for Clinical and Experimental Ophthalmology [Internet]. Springer; 2021 [cited 2026 June 26];259(8):2057–67. Available from: https://idp.springer.com/authorize/casa?redirect_uri=https://link.springer.com/article/10.1007/s00417-021-05081-8&casa_token=_eBl_lh3Az4AAAAA:dAjJ0ZC-yU1NYR_VpFN59bECeD2GCJFPG58D7EcMVOLHQ44W30U-lgntzuwob0LAEM6lEJo6tK0ZVGAe1g
Ahuja P, Dadachanji Z, Shetty R, Nagarajan SA, Khamar P, Sethu S, et al. Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of Keratoconus. Indian journal of ophthalmology [Internet]. Medknow; 2020 [cited 2026 June 26];68(10):2067–74. Available from: https://journals.lww.com/ijo/fulltext/2020/68100/Relevance_of_IgE,_allergy_and_eye_rubbing_in_the.6.aspx
Mirza E, Oltulu R, Oltulu P, Mirza GD, Okka M. Dry eye disease and ocular surface characteristics in patients with keratoconus. Saudi Journal of Ophthalmology [Internet]. Medknow; 2022 [cited 2026 June 26];36(1):117–21. Available from: https://journals.lww.com/sjop/fulltext/2022/36010/Dry_eye_disease_and_ocular_surface_characteristics.19.aspx
Ambrósio R, Caiado ALC, Guerra FP, Louzada R, Roy AS, Luz A, et al. Novel Pachymetric Parameters Based on Corneal Tomography for Diagnosing Keratoconus. J Refract Surg. 2011;27(10):753–8. DOI: 10.3928/1081597X-20110721-01
Zhao Z, Liu Y, Zou Y, Liu Y, Yu M. Intense pulsed light alleviates keratoconus by improving the local corneal microenvironment. Medical Hypotheses [Internet]. Elsevier; 2025 [cited 2026 June 26];194:111526. Available from: https://www.sciencedirect.com/science/article/pii/S030698772400269X
Lasagni Vitar RM, Bonelli F, Rama P, Ferrari G. Nutritional and metabolic imbalance in keratoconus. Nutrients [Internet]. MDPI; 2022 [cited 2026 June 26];14(4):913. Available from: https://www.mdpi.com/2072-6643/14/4/913
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Muhammad Kashif (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
